Xiaoling Xie

9PUBLICATIONS
11CO-AUTHORS
Innate immunityAutoimmunityHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 26, 2026
FGF18 mediates fibroblast-leukemia crosstalk to promote acute myeloid leukemia progression.

|Oct 23, 2023
Low doses of IFN-γ maintain self-renewal of leukemia stem cells in acute myeloid leukemia.

Xiaoling Xie, Wuju Zhang, Xuan Zhou

|Aug 04, 2023
Histone acetylation by HBO1 (KAT7) activates Wnt/β-catenin signaling to promote leukemogenesis in B-cell acute lymphoblastic leukemia.

Hao Wang, Yingqi Qiu, Honghao Zhang

|Mar 31, 2023
TREM2 acts as a receptor for IL-34 to suppress acute myeloid leukemia in mice.

Xiaoling Xie, Wuju Zhang, Min Xiao

|Mar 18, 2023
Loss of EPS8 sensitizes non-small-cell lung carcinoma to chemotherapy-induced DNA damage.

Yingqi Qiu, Binyan Xu, Jianhua Feng

|Apr 20, 2021
Author Correction: Therapeutic vaccination against leukaemia via the sustained release of co-encapsulated anti-PD-1 and a leukaemia-associated antigen.

Xiaoling Xie, Yuxing Hu, Tong Ye

Pageof 2

Frequent Collaborators

9 joint publications

Yuhua Li

2 joint publications

Tong Ye

2 joint publications

Xiaoyong Gao

2 joint publications

Wei Wei